Company news
EMvision Medical Devices Ltd. news in 2023
EMvision Medical Devices Ltd.'s news releases, calls and decks from 2023, newest first.
EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
December 17, 2023
Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
November 26, 2023
AGM CEO Presentation including Latest Imaging Case Studies
November 14, 2023
AGM Chairman's Address
November 14, 2023
Gen 2 Advanced Prototype Assembled
October 23, 2023
Encouraging Interim Clinical Trial Results
October 9, 2023
Appendix 4E & Annual Report to 30 June 2023
August 29, 2023
Latest Imaging and Clinical Trial Insights
August 21, 2023
Clinical Trial Progress & ASA Milestone Achieved
July 26, 2023
Recruitment at Royal Melbourne Hospital Commences
June 28, 2023
$1.75M Manufacturing Grant Payment Received
June 12, 2023
Leadership Transition
May 30, 2023
Stage 2 of Clinical Trial Activated
May 28, 2023
Product Development Milestones & Grant Funding Achieved
April 16, 2023
CEO Half-Year Update
February 27, 2023
Clinical Trial Stage 1 Enrolment Completed
February 20, 2023
Trial Progressing on Target and ASA Milestone Achieved
January 24, 2023
Decks in 2023
- Shareholder Meeting (November 2023)
Shareholder meeting · 10 slides · Nov 15, 2023
- ASX Small and Mid-Cap Conference (September 2023)
Conference · 19 slides · Sep 20, 2023